These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18327030)

  • 1. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
    Almadori G; Bussu F; Paludetti G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in squamous cell carcinomas of the head and neck.
    Liu M; Weynand B; Delos M; Marbaix E
    Acta Otorhinolaryngol Belg; 1999; 53(3):155-60. PubMed ID: 10635383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular approaches to the staging of head and neck carcinomas (review).
    Gasparotto D; Maestro R
    Int J Oncol; 2007 Jul; 31(1):175-80. PubMed ID: 17549419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
    Le QT; Giaccia AJ
    Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic cutaneous squamous cell carcinoma to the parotid and cervical lymph nodes: treatment and outcomes.
    Bumpous J
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):122-5. PubMed ID: 19346945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
    Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.
    Palme CE; MacKay SG; Kalnins I; Morgan GJ; Veness MJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):103-6. PubMed ID: 17413411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers.
    Takes RP
    Oral Oncol; 2004 Aug; 40(7):656-67. PubMed ID: 15172634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
    Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?
    Haffty BG
    Nat Clin Pract Oncol; 2005 Mar; 2(3):132-3. PubMed ID: 16264904
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biomarkers in HNSCC: prognostic and therapeutic implications.
    Hussein MR; Cullen K
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):116-24. PubMed ID: 12113118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.
    Rickman DS; Millon R; De Reynies A; Thomas E; Wasylyk C; Muller D; Abecassis J; Wasylyk B
    Oncogene; 2008 Nov; 27(51):6607-22. PubMed ID: 18679425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic factors for head and neck cancer].
    Fujieda S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.